Indefinite Delivery Contract SPE2DU25D9539

The Department of Defense's Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is a crucial component of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V, which aims to establish multiple regional prime vendor contracts valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to the Department of Defense, United States Coast Guard, and other government agencies. The contract is awarded on a lowest price technically acceptable basis, and the government intends to use a reverse auction strategy to obtain the best distribution fees from the primary suppliers.